article thumbnail

How Real-World Data Supports Pharmaceutical Drug Development

IT Toolbox

The post How Real-World Data Supports Pharmaceutical Drug Development appeared first on Spiceworks. Real-world Data (RWD) answers questions that clinical trials can’t answer.

article thumbnail

Best Training Methods for the Pharmaceutical Industry

Kitaboo

Pharmaceutical Industry today, is a goldmine of opportunities. The global pharmaceutical market was estimated at approximately $935 billion in 2017 and is bound to reach $1170 billion by 2021. And for a company to succeed, the people who make it, i.e., its employees, should be updated with all the recent developments.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Zymeworks nabs $350M from Jazz Pharmaceuticals after release of clinical trial data

GeekWire

Zymeworks will receive $350 million from Jazz Pharmaceuticals in return for the right to develop and commercialize Zymeworks’ lead drug candidate, zanidatamab, in the U.S., Europe and Japan.

article thumbnail

Tadataka Yamada, 1945-2021: Pioneer in drug development led global health at Gates Foundation

GeekWire

Tadataka Yamada, a pioneer in drug and vaccine development who helped forge numerous biotech companies and spent six years at the Bill and Melinda Gates Foundation as head of global health, died Wednesday morning of natural causes at his home in Seattle. Tadataka “Tachi” Yamada. Twitter Photo via @TachiYamada).

article thumbnail

Researcher with Seattle ties awarded $4.2M to develop DNA vaccine against COVID-19

GeekWire

John Lewis, co-founder and chief scientific officer at Seattle’s OncoSenX, and co-founder and CEO of Entos Pharmaceuticals in Edmonton, Alberta. The research will be done at Entos Pharmaceuticals in Edmonton, Alberta, where Lewis is a co-founder and CEO. LinkedIn Photo).

Research 145
article thumbnail

Biggest roadblocks that AI-powered drug development faced in 2022

Dataconomy

AI-powered drug development can shorten the time it takes to acquire and access information, cutting pharmaceutical development time in half and keeping the cost of new medications under control. This is becoming increasingly crucial as the cost of discovering and developing new drugs rises.

article thumbnail

FDA Approves a New RNA-Based Treatment to Lower Cholesterol

Gizmodo

The Food and Drug Administration has approved a novel type of cholesterol-lowering drug jointly developed by Alnylam Pharmaceuticals and Novartis. The treatment, called Leqvio, uses RNA to help keep levels of low-density lipoprotein (LDL) cholesterol in the blood low, which is important for people with certain… Read more.